These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22683459)

  • 41. Ancient remedy performs new tricks.
    Mervis J
    Science; 1996 Aug; 273(5275):578. PubMed ID: 8701308
    [No Abstract]   [Full Text] [Related]  

  • 42. Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia.
    Carmosino I; Latagliata R; Avvisati G; Breccia M; Finolezzi E; Lo Coco F; Petti MC
    Haematologica; 2004 May; 89(5):615-7. PubMed ID: 15136230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
    Masamoto Y; Nannya Y; Arai S; Koike Y; Hangaishi A; Yatomi Y; Kurokawa M
    Br J Haematol; 2009 Mar; 144(5):798-9. PubMed ID: 19036092
    [No Abstract]   [Full Text] [Related]  

  • 44. Increased erythropoietin level and reticulocyte count during arsenic trioxide therapy.
    Kajiguchi T; Yamamoto K; Sawa M; Emi N; Naoe T
    Leukemia; 2005 Apr; 19(4):674-6. PubMed ID: 15690072
    [No Abstract]   [Full Text] [Related]  

  • 45. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
    Ma J
    Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
    [No Abstract]   [Full Text] [Related]  

  • 46. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
    Tong H; Li K; Mei C; Wang H; Chen Z; Jin J
    Ann Hematol; 2011 Dec; 90(12):1493-4. PubMed ID: 21431323
    [No Abstract]   [Full Text] [Related]  

  • 47. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.
    Ohnishi K; Yoshida H; Shigeno K; Nakamura S; Fujisawa S; Naito K; Shinjo K; Fujita Y; Matsui H; Takeshita A; Sugiyama S; Satoh H; Terada H; Ohno R
    Ann Intern Med; 2000 Dec; 133(11):881-5. PubMed ID: 11103058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute intestinal pseudo-obstruction after induction treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
    Park JA; Yun JH; Kang HJ; Shin HY; Ahn HS
    Pediatr Blood Cancer; 2008 Apr; 50(4):872-4. PubMed ID: 17635008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arsenicals in hematologic cancers.
    Novick SC; Warrell RP
    Semin Oncol; 2000 Oct; 27(5):495-501. PubMed ID: 11049017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Herpes zoster during treatment with arsenic trioxide.
    Tanvetyanon T; Nand S
    Ann Hematol; 2004 Mar; 83(3):198-200. PubMed ID: 15064871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arsenic trioxide.
    Wilkinson K
    Clin J Oncol Nurs; 2001; 5(5):237-8. PubMed ID: 11899773
    [No Abstract]   [Full Text] [Related]  

  • 52. Curing APL through PML/RARA degradation by As2O3.
    Lallemand-Breitenbach V; Zhu J; Chen Z; de Thé H
    Trends Mol Med; 2012 Jan; 18(1):36-42. PubMed ID: 22056243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia.
    Ammatuna E; Cavaliere A; Divona M; Amadori S; Scambia G; Lo-Coco F
    Br J Haematol; 2009 Aug; 146(3):341. PubMed ID: 19545283
    [No Abstract]   [Full Text] [Related]  

  • 54. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles.
    Yamazaki K; Terada H; Satoh H; Naito K; Takeshita A; Uehara A; Katoh H; Ohnishi K; Hayashi H
    Circ J; 2006 Nov; 70(11):1407-14. PubMed ID: 17062962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series.
    Gupta S; Bagel B; Gujral S; Subramanian PG; Khattry N; Menon H; Nair R
    Leuk Lymphoma; 2012 Nov; 53(11):2192-4. PubMed ID: 22452590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure.
    Hai JJ; Gill H; Tse HF; Kumana CR; Kwong YL; Siu CW
    Ann Hematol; 2015 Mar; 94(3):501-3. PubMed ID: 25079038
    [No Abstract]   [Full Text] [Related]  

  • 57. Does arsenic trioxide impact fertility?
    Stein EM; Tallman MS
    Leuk Lymphoma; 2012 Nov; 53(11):2099-100. PubMed ID: 22524541
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome.
    Hassaballa HA; Lateef OB; Silver MR; Balk RA
    J Crit Care; 2005 Mar; 20(1):111-3. PubMed ID: 16015525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged oral arsenic trioxide therapy and nephrolithiasis [corrected].
    Au WY; Tam S; Fong BM; Ho KL; Tam PC; Kwong YL
    Leuk Lymphoma; 2007 Nov; 48(11):2233-4. PubMed ID: 17926176
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Huff J; Waalkes M; Nyska A; Chan P
    J Natl Cancer Inst; 1999 Oct; 91(19):1690-1. PubMed ID: 10511603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.